US Department of Health and Human Services and SAMHSA's National Clearinghouse For Alcohol and Drug Information DHHS SAMHSA's National Clearinghouse For Alcohol and Drug Information
Photo Of Person One Photo Of Person Two Photo Of Person Three Photo Of Person Four
Drugs
Audiences
Issues
Publications
Newsroom
Calendar
Resources
Research

This Web site is a component of the SAMHSA Health Information Network.

Publications
Publications

Quick Find & Order
Top 50
Pubs in Series
Cost Recovery Items
Posters
Videos
Spanish
Drugs
Audiences
Issues

This Web site is a component of the SAMHSA Health Information Network.

  

Assessment and Treatment Planning for Cocaine-Abusing Methadone-Maintained Patients
Treatment Improvement Protocol (TIP) Series10

Appendix D - TB/PPD Testing - Sample Forms

TB/PPD Testing

Patient Name_________________________ SS#__________ Unit: ... Sat ... AC ... SUPT
Section A (History)
  • Confirmed Negative TB test in past 30 days: ... Yes ... No

    Date (Mo/Day/Yr) _________ Location ______________
If YES, DO NOT TEST; SKIP sections B and C; go to section D
  • Previous Positive test for tuberculosis: ... Yes ... No

    Date (Mo/Day/Yr) _________ Location ______________
If YES (positive TB history), DO NOT TEST; go to section C - If NO, complete section B
Section B (If Previously Negative)
  • Has patient ever had mumps? ... Yes ... No ... Unknown
  • Is patient allergic to eggs?... Yes ... No
Instructions: If patient is allergic to eggs, DO NOT USE MUMPS. Specify amount of erythema and induration in mm. First test for TB is positive if there is palpable induration of at least 5 mm. Test for mumps is positive if there is erythema of at least 5 mm. Test for Candida is positive if the erythema and induration are at least 5 mm. Repeat test for TB, if indicated, within 14 days. Second test for TB is positive if there is palpable induration at least 6 mm larger than was present from the first TB test.
  • Results:... Positive ... Negative ... Anergic ... Equivocal ... No Show
If POSITIVE, complete section C
TestPlacement24 hr 48 hr72 hr
TB-Initial    
Mumps    
Candida    
Cocci    
Date/Time    
Initials    
TB-Repeat    
Date/Time    
Initials    
Section C (If Previously or Currently Positive)
  • Type:...
    Active ...
    Latent ...
    Unknown
  • Referral: ...
    IDC ...
    Pulmonary Clinic...
    Hospital ...
    Private Physician ...
    None/Dropped Out ...
    Other__________________________
  • Treatment Status: ...
    Initiated/Continuing ...
    Discontinued ...
    Completed ...
    Not Initiated/Contraindicated ...
    Unknown
  • If Treatment Discontinued or Not Initiated, reason: ...
    Previous Adequate Treatment ...
    Age ...
    Noncompliance ...
    Poor Liver Function ...
    Other Medical Problem __________
  • Treatment:
dose/frequencystart daterecommended end dateactual end date
... Aminosalicylic acid    
... Ethambutol HCL    
... Isoniazid & Pyridoxine(INH & B6)    
... Rifampin    
... Streptomycin    
... Other    
Section D
  • HIV Status: ...
    Positive ...
    Negative ...
    Unknown
If POSITIVE, date of EARLIEST positive test (Mo/Yr) ______________
If NEGATIVE, date of MOST RECENT negative test (Mo/Yr) _____________

Substance Abuse Inpatient Unit

TB Testing
Supplemental Questions
Chest X-ray results:NAD / Consistent with TB / Equivocal
Followup (after discharge):
 None indicated
 Repeat Chest X-ray (suggested date) ____________
 Repeat skin testing (suggested date)____________
 Infectious disease appointment (date)____________
 Pulmonary appointment (date)____________
 CDC report filed
 Unable to follow up: no known address / premature discharge
Important statistics:
 Residence: home / homeless / shelter / unknown
 Imprisonment: past / current
 IV drug abuse: past 6 months / remote history / never
 Three highest ranked drugs of use:
1. ____________2. ____________3. ____________
DSM III R Axis I_______________
 _______________
 _______________
Axis II_______________
_______________
Signature
_______________
Date

Substance Abuse Treatment Outpatient Clinic

PPD Testing
Supplemental Questions
1. When was your last chest X-ray?___________
Date
2. When were you last skin-tested for tuberculosis? ___________
Date
3. Were you tested with a single poke from a needle (PPD) or with four pokes from a small plastic applicator (tine test)? ___________
Date
4. Did you get tested with controls (anergy panel)? ___________
Y/N
5. Drug use in past 6-12 months (check if yes):
IV Heroin _____Other opioids _____Sedative/Hypnotic _____
IV Cocaine _____Smoked Crack _____Snorted Cocaine ______
IV Amphetamine ______Other Amphetamine _____PCP _____
Alcohol _____Cigarettes _____Marijuana _____
Hallucinogens _____
6. Residence in the past 6-12 months (check if yes)
Home _____Homeless _____Shelter _____ Unknown _____
ORDERS:
  1. Place the PPD skin test with two of the anergy panels on the same forearm with the PPD nearest the elbow and the Coccidioidin or Candida nearest the hand. DO NOT use mumps if allergic to eggs.
  2. Read and record the results at 24, 48 and 72 hours.
  3. DO NOT DO SKIN TESTING if the patient has ever tested positive for tuberculosis.
  4. DO NOT DO SKIN TESTING if the patient has ever been treated for tuberculosis.
  5. Repeat PPD test within 14 days if patient was anergic or had a skin reaction which would be interpreted as negative (less than 5 mm).
_______________
Date
____________________
Physician's Signature
____________________
(Signatures of all RNs/LVn involved in testing)
_______________
Date
 



NCADI Live Help
Send this Page to a Friend E-mail this Page
Printer Friendly Version Print this Page
Join the eNetwork Join the eNetwork
Contact Us Contact Us
Link to Us Link to Us
Home Home

Fetal Alcohol Syndrome (new window)

Multimedia
 
Initiatives  |   Funding  |   Home
U.S. Department of Human and Health Services U.S. Department of Health and Human Services
Substance Abuse and Mental Health Services Administration
Center for Mental Health Services
Center for Substance Abuse Prevention
Center for Substance Abuse Treatment
 
National Clearinghouse for Alcohol and Drug Information
About Us | Privacy | Accessibility | Disclaimer | Site Map | Awards |Customer Service
SAMHSA Home | Freedom of Information Act | Department of Health and Human Services | The White House | USA.gov